These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31653686)

  • 1. Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
    Chiou J; Chang YC; Tsai HF; Lin YF; Huang MS; Yang CJ; Hsiao M
    Cancer Res; 2019 Dec; 79(24):6113-6125. PubMed ID: 31653686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.
    Bae K; Park KE; Han J; Kim J; Kim K; Yoon KA
    Oncotarget; 2016 Apr; 7(14):18076-84. PubMed ID: 26716515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
    Chiou J; Su CY; Jan YH; Yang CJ; Huang MS; Yu YL; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9830. PubMed ID: 28852126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
    Ni X; Cao X; Wu Y; Wu J
    Oncol Rep; 2018 Jan; 39(1):13-20. PubMed ID: 29115636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity.
    Kudo-Saito C; Ishida A; Shouya Y; Teramoto K; Igarashi T; Kon R; Saito K; Awada C; Ogiwara Y; Toyoura M
    Cell Rep; 2018 Aug; 24(7):1790-1801. PubMed ID: 30110636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.
    Gu C; Wang X; Long T; Wang X; Zhong Y; Ma Y; Hu Z; Li Z
    Cell Death Dis; 2018 May; 9(6):654. PubMed ID: 29844309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
    Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
    Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
    Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.
    Zhou X; Xiao X; Huang T; Du C; Wang S; Mo Y; Ma N; Murata M; Li B; Wen W; Huang G; Zeng X; Zhang Z
    Oncotarget; 2016 Mar; 7(13):16433-44. PubMed ID: 26918942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.
    Kataoka Y; Ohshio Y; Teramoto K; Igarashi T; Asai T; Hanaoka J
    Oncol Rep; 2019 Feb; 41(2):853-862. PubMed ID: 30535445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.
    Lau MC; Ng KY; Wong TL; Tong M; Lee TK; Ming XY; Law S; Lee NP; Cheung AL; Qin YR; Chan KW; Ning W; Guan XY; Ma S
    Cancer Res; 2017 Nov; 77(21):5886-5899. PubMed ID: 28883005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development.
    Geng Y; Dong Y; Yu M; Zhang L; Yan X; Sun J; Qiao L; Geng H; Nakajima M; Furuichi T; Ikegawa S; Gao X; Chen YG; Jiang D; Ning W
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7058-63. PubMed ID: 21482757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
    Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
    BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of Long Noncoding RNA
    Su W; Feng S; Chen X; Yang X; Mao R; Guo C; Wang Z; Thomas DG; Lin J; Reddy RM; Orringer MB; Chang AC; Yang Z; Beer DG; Chen G
    Cancer Res; 2018 Jun; 78(12):3207-3219. PubMed ID: 29669758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
    Shang H; Liu X; Guo H
    Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin-like 1 in vertebrate development.
    Sylva M; Moorman AF; van den Hoff MJ
    Birth Defects Res C Embryo Today; 2013 Mar; 99(1):61-9. PubMed ID: 23723173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
    Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
    Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer.
    Yang YG; Koh YW; Sari IN; Jun N; Lee S; Phi LTH; Kim KS; Wijaya YT; Lee SH; Baek MJ; Jeong D; Kwon HY
    Int J Cancer; 2019 Apr; 144(8):2020-2032. PubMed ID: 30318841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.